Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling  Hsiu-Chung Ou, PhD, Wen-Jane Lee, PhD, Ching-Mei.

Slides:



Advertisements
Similar presentations
GENISTEIN-MEDIATED PROTECTION AGAINST INTERLEUKIN-4-INDUCED INFLAMMATORY PATHWAYS IN HUMAN VASCULAR ENDOTHELIAL CELLS Yong Woo Lee 1, Bernhard Hennig 2,
Advertisements

Signal regulatory protein-α interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease  Sandhya S. Thomas, Yanjun Dong,
Proinflammatory cytokine–induced and chemical mediator–induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein.
EGCG prevents PCB-126-induced endothelial cell inflammation via epigenetic modifications of NF-κB target genes in human endothelial cells  Dandan Liu,
Chrysin restores PDGF-induced inhibition on protein tyrosine phosphatase and reduces PDGF signaling in cultured VSMCs  Huey-Ming Lo, Min-Wen Wu, Shiow-Lin.
Volume 68, Issue 4, Pages (October 2005)
Rap1 GTPase Inhibits Tumor Necrosis Factor-α–Induced Choroidal Endothelial Migration via NADPH Oxidase– and NF-κB–Dependent Activation of Rac1  Haibo.
Bone Morphogenic Protein 4 Produced in Endothelial Cells by Oscillatory Shear Stress Induces Monocyte Adhesion by Stimulating Reactive Oxygen Species Production.
Volume 62, Issue 6, Pages (December 2002)
Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells  Wen-Jane Lee, PhD, Hsiu-Chung.
Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action  Wei-Wen.
Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances.
Reduced hind limb ischemia-reperfusion injury in Toll-like receptor-4 mutant mice is associated with decreased neutrophil extracellular traps  Rahmi Oklu,
Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like.
Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R
Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic.
Prevention of ischemia-reperfusion injury in cardiac surgery: Therapeutic strategies targeting signaling pathways  Kay Maeda, MD, PhD, Marc Ruel, MD,
Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells  Wen-Jane Lee, PhD, Hsiu-Chung.
Volume 44, Issue 5, Pages (May 2006)
Volume 83, Issue 4, Pages (April 2013)
Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells  Hi Bahl.
Crude extracts of Solanum lyratum protect endothelial cells against oxidized low-density lipoprotein-induced injury by direct antioxidant action  Wei-Wen.
M. -H. Moon, J. -K. Jeong, Y. -J. Lee, J. -W. Seol, C. J. Jackson, S
Peroxynitrite-modified collagen-II induces p38/ERK and NF-κB-dependent synthesis of prostaglandin E2 and nitric oxide in chondrogenically differentiated.
Signal transduction pathways triggered by the FcϵRIIb receptor (CD23) in human monocytes lead to nuclear factor-κB activation  Rosa M. Ten, MD, PhDa,
Characterization of TNF-α– and IL-17A–Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ  Claus Johansen, Trine.
Sun A. Ham, Eun S. Kang, Hanna Lee, Jung S. Hwang, Taesik Yoo, Kyung S
NF-κBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes  Dr C. Lianxu, Ph.D.,
Y. Higashimoto, M. Ohata, Y. Yamagata, T. Iwata, M. Masuda, T
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Nod2-Induced Autocrine Interleukin-1 Alters Signaling by ERK and p38 to Differentially Regulate Secretion of Inflammatory Cytokines  Matija Hedl, Clara.
Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes  N. Chabane, M.Sc.,
Interferon-γ Protects from Staphylococcal Alpha Toxin-Induced Keratinocyte Death through Apolipoprotein L1  Anne M. Brauweiler, Elena Goleva, Donald Y.M.
Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated.
Sandhya K. Balaram, MD, Devendra K. Agrawal, PhD, R
Volume 68, Issue 6, Pages (December 2005)
Indomethacin Sensitizes TRAIL-Resistant Melanoma Cells to TRAIL-Induced Apoptosis through ROS-Mediated Upregulation of Death Receptor 5 and Downregulation.
Translocation of protein kinase C isoforms is involved in propofol-induced endothelial nitric oxide synthase activation  L. Wang, B. Wu, Y. Sun, T. Xu,
Α-MSH inhibits TNF-α-induced matrix metalloproteinase-13 expression by modulating p38 kinase and nuclear factor κB signaling in human chondrosarcoma HTB-94.
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Volume 79, Issue 10, Pages (May 2011)
Sphingosine-1-phosphate–induced oxygen free radical generation in smooth muscle cell migration requires Gα12/13 protein-mediated phospholipase C activation 
Ambient pressure upregulates nitric oxide synthase in a phosphorylated-extracellular regulated kinase– and protein kinase C–dependent manner  Angela G.
Tumor necrosis factor α up-regulates endometrial milk fat globule–epidermal growth factor 8 protein production via nuclear factor κB activation, resulting.
Simvastatin Protects Human Melanocytes from H2O2-Induced Oxidative Stress by Activating Nrf2  Yuqian Chang, Shuli Li, Weinan Guo, Yuqi Yang, Weigang Zhang,
Effect of advanced glycation end-products on gene expression and synthesis of TNF-α and endothelial nitric oxide synthase by endothelial cells  Gloria.
Evidence for two distinct pathways in TNFα-induced membrane and soluble forms of ICAM-1 in human osteoblast-like cells isolated from osteoarthritic patients 
Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression  Toran Sanli,
Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes  A.W.M. Cheng,
Anti-Inflammatory Activity of Sertaconazole Nitrate Is Mediated via Activation of a p38– COX-2–PGE2 Pathway  Runa Sur, Jeffrey M. Babad, Michelle Garay,
Volume 68, Issue 4, Pages (October 2005)
Sang-Wahn Koo, Katherine A. Casper, Kristen B. Otto, Amy K
Estrogen receptor β agonist diarylpropionitrile inhibits lipopolysaccharide-induced regulated on activation normal T cell expressed and secreted (RANTES)
Volume 132, Issue 5, Pages (May 2007)
Cis-Urocanic Acid Enhances Prostaglandin E2 Release and Apoptotic Cell Death via Reactive Oxygen Species in Human Keratinocytes  Kazuyo Kaneko, Susan.
Upregulation of Tenascin-C Expression by IL-13 in Human Dermal Fibroblasts via the Phosphoinositide 3-kinase/Akt and the Protein Kinase C Signaling Pathways 
Secretory Phospholipase A2 Inhibition Attenuates Intercellular Adhesion Molecule-1 Expression in Human Esophageal Adenocarcinoma Cells  Miral R. Sadaria,
P38 Mitogen-activated Protein Kinase and Extracellular Signal-regulated Kinases Play Distinct Roles in the Activation of Dendritic Cells by Two Representative.
The effects of ginsenoside Rb1 on endothelial damage and ghrelin expression induced by hyperhomocysteine  Zhiwei Xu, PhD, Taohua Lan, MD, Weikang Wu,
All-Trans-Retinoic Acid Induces Interleukin-8 via the Nuclear Factor-κB and p38 Mitogen-Activated Protein Kinase Pathways in Normal Human Keratinocytes 
Activation and Translocation of p38 Mitogen-Activated Protein Kinase After Stimulation of Monocytes With Contact Sensitizers  Pia Brand, Sibylle Plochmann,
Chi-Hyun Park, Youngji Moon, Chung Min Shin, Jin Ho Chung 
Volume 65, Issue 5, Pages (May 2004)
SIRT1, a Class III Histone Deacetylase, Regulates LPS-Induced Inflammation in Human Keratinocytes and Mediates the Anti-Inflammatory Effects of Hinokitiol 
Prasun K. Datta, Elias A. Lianos  Kidney International 
Expression of Matrix Metalloproteinase-13 Is Controlled by IL-13 via PI3K/Akt3 and PKC-δ in Normal Human Dermal Fibroblasts  Chikako Moriya, Masatoshi.
Zhenying Nie, PhD, Cole S. Nelson, PhD, David B. Jacoby, MD, Allison D
IGF-1 regulation of type II collagen and MMP-13 expression in rat endplate chondrocytes via distinct signaling pathways  M. Zhang, Ph.D., Q. Zhou, M.D.,
Runa Sur, Peter A. Lyte, Michael D. Southall 
Panagiotis Kougias, MD, Hong Chai, MD, PhD, Peter H. Lin, MD, Alan B
Presentation transcript:

Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling  Hsiu-Chung Ou, PhD, Wen-Jane Lee, PhD, Ching-Mei Wu, MS, Judy Fuh-Meei Chen, PhD, Wayne Huey-Herng Sheu, MD, PhD  Journal of Vascular Surgery  Volume 55, Issue 4, Pages 1104-1115 (April 2012) DOI: 10.1016/j.jvs.2011.10.011 Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 1 Effects of aspirin on resistin-induced reactive oxygen species (ROS) generation in endothelial cells. Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with various concentrations of aspirin (10-500 μg/mL), followed by treatment with 100 ng/mL resistin for 48 hours. At the end of treatment, HUVECs were incubated with the superoxide-sensitive fluorescent probe dihydroethidium (DHE; 10 μM) for 1 hour. A, Fluorescence images show the ROS level in control cells (left) and in HUVECs stimulated with resistin (middle) in the presence of 500 μg/mL aspirin (right). B, Fluorescence intensity of HUVECs was measured with a fluorescence microplate reader. Fluorescence distribution of DHE oxidation was expressed as a percentage of increased intensity. The activities of superoxide dismutase (SOD) (C) and catalase (D) in HUVECs stimulated with resistin in the absence or presence of indicated concentrations of aspirin were determined. Data are expressed as the mean ± SEM of three independent analyses. #P < .05 vs untreated control; *P < .05 compared with resistin treatment. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 2 Aspirin attenuated the level of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase membrane assembly. Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with the indicated concentrations of aspirin followed by stimulation with resistin (100 ng/mL) for 1 hour (A-C) or 24 hours (D-F). Preparation of membrane and cytosolic proteins is described in the Materials and Methods section. The levels of cytosolic protein and membrane protein were normalized to the levels of β-actin and flotillin-1, respectively. Representative Western blots and summary data showing that aspirin protected against resistin-induced p47phox and Rac-1 translocation to the plasma membrane, as well as gp91phox and p22phox expression. The values represent means ± SEM from three separate experiments. #P < .05 vs untreated control; *P < .05 compared with resistin treatment. DPI, Diphenyleneiodonium. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 3 Aspirin prevented resistin-induced PKC-α translocation via AMP-activated protein kinase (AMPK) phosphorylation. Human umbilical vein endothelial cells (HUVECs) were pretreated with aspirin (10-500 μg/mL) or diphenyleneiodonium (DPI; 5 μM) or 5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) (500 μM) for 2 hours followed by exposure to resistin (100 ng/mL) for a further 1-hour period. Representative Western blots and summary data show that aspirin protected against resistin-induced AMPK dephosphorylation (A and B) and PKC-α translocation to the plasma membrane (C and D). In AMPK knockdown experiments, HUVECs were transfected with AMPKα1 siRNA for 24, 48, and 72 hours. Protein expression of AMPK (E) and phosphorylated acetyl-CoA carboxylase (p-ACC) (F) were checked by Western blots. The effects of aspirin on resistin-induced membrane translocation of PKC-α and p47phox were abolished in cells that had been transfected with AMPK siRNA for 48 hours (G-I). Preparation of membrane and cytosolic proteins is described in the Materials and Methods section. The levels of cytosolic and membrane protein were normalized to the levels of β-actin and flotillin-1, respectively. The values represent means ± SEM of three separate experiments. #P < .05 vs untreated control; *P < .05 compared with resistin treatment; &P < .05 vs resistin + aspirin treatment. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 4 The protective effects of aspirin involve AMP-activated protein kinase (AMPK)/Akt/endothelial nitric oxide synthase (eNOS) activation. Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with the indicated concentrations of aspirin, aspirin plus Compound C, or 5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) followed by resistin (100 ng/mL) for an additional 1-hour period. In a parallel experiment, HUVECs were transfected with AMPK siRNA for 48 hours before treatment of resistin. Western blot analysis for Akt, eNOS, phospho-Akt (p-Akt), and phospho-eNOS (p-eNOS) (A). The values represent means ± SEM of three separate experiments (B and C). #P < .05 vs untreated control; *P < .05 compared with treatment; &P < .05 vs resistin + aspirin treatment. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 5 Effect of aspirin on p38 mitogen-activated protein kinase (p38 MAPK)-mediated NF-κB activation caused by resistin. Pretreatment of human umbilical vein endothelial cells (HUVECs) with indicated concentrations of aspirin, or an inhibitor of p38 MAPK (SB203580), attenuated p38 MAPK activation, IκB-α degradation, and NF-κB activation caused by resistin. HUVECs were pretreated with various concentrations of aspirin or SB203580 for 2 hours, followed by incubation with resistin (100 ng/mL) for 1 hour. At the end of the incubation period, cells were lysed and proteins were analyzed by Western blot. Protein levels of phosphor-p38 MAPK, NF-κB, and IκB-α were normalized to the level of total p38 MAPK, PCNA, and β-actin, respectively (A). Data illustrated on the graph bars represent the mean ± SEM of three separate experiments (B-D). #P < .05 vs untreated control; *P < .05 compared to resistin treatment. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 6 Aspirin suppressed the resistin-induced downregulation of endothelial nitric oxide synthase (eNOS), upregulation of inducible NO synthase (iNOS), the nitration of tyrosine residues (A and B), and resistin-enhanced nitrous oxide (NO) release (C). Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with the indicated concentrations of aspirin followed by stimulation with resistin (100 ng/mL) for 48 hours. At the end of the incubation period, levels of eNOS, iNOS, and nitrotyrosine protein (normalized to the levels of β-actin) were determined by immunoblotting; content of NO was assayed using Griess reagent. The values represent means ± SEM from three separate experiments. #P < .05 vs untreated control; *P < .05 compared to resistin treatment. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 7 Effect of aspirin on resistin-induced mRNA and protein expression of inflammatory cytokines, adhesion molecules, and monocytic cells adherence. Human umbilical vein endothelial cells (HUVECs) were pretreated for 2 hours with or without indicated concentrations of aspirin (10, 100, 300, and 500 μg/mL) followed by resistin (100 ng/mL) incubation for 48 hours. mRNA levels of interleukin (IL)-6, IL-8 (A), and intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) as well as E-selectin (B) were determined by real-time polymerase chain reaction (PCR). Protein levels of IL-6, IL-8 (C), and ICAM-1, VCAM-1, as well as E-selectin (D) were determined by enzyme-linked immunosorbent assay (ELISA). E and F, Cells were pretreated with each inhibitor 1 hour before aspirin treatment and then incubated for 48 hours with resistin (100 ng/mL). Resistin-induced adhesiveness of monocytic leukemia cells (THP-1) to HUVECs was measured as described in the Materials and Methods section. The values represent means ± SEM from three separate experiments. #P < .05 vs untreated control; *P < .05 compared with resistin treatment; &P < .05 vs resistin + aspirin treatment. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions

Fig 8 Summary and working hypothesis showing the signaling cascades involved in the attenuation of inflammatory responses in resistin-exposed cells treated with aspirin. The → indicates activation or induction, and ⊣ indicates inhibition or blockade. Resistin has been reported to be involved in the inflammatory process, which is a common feature in metabolic syndrome, insulin resistance status, and vascular diseases. This study underscores the potential clinical benefits and application of aspirin in prevention of obese-associated vascular dysfunction. AMPK, AMP-activated protein kinase; eNOS, endothelial nitric oxide synthase; ICAM, intercellular adhesion molecule; IL, interleukin; iNOS, inducible nitric oxide snythase; NADPH, nicotinamide adenine dinucleotide phosphate; p38 MAPK, p38 mitogen-activated protein kinase; ROS, reactive oxygen species; SOD, superoxide dismutase; VCAM, vascular cell adhesion molecule. Journal of Vascular Surgery 2012 55, 1104-1115DOI: (10.1016/j.jvs.2011.10.011) Copyright © 2012 Society for Vascular Surgery Terms and Conditions